Evotec SE (EVO) Research & Development (2020 - 2025)
Evotec SE's (EVO) quarterly Research & Development came in at $43.7 million in Q4 2025, down 19.66% year-on-year from $54.4 million in Q4 2024, and up 429065.53% quarter-over-quarter from -$10186.0 in Q3 2025.
Evotec SE (EVO) Research & Development (2020 - 2025) Analysis & Trends
Evotec SE has disclosed Research & Development across 6 years of filings, most recently posting $43.7 million for Q4 2025.
- Research & Development for Q4 2025 came in at $43.7 million, down 19.66% year-over-year; the trailing twelve-month figure through Dec 2025 was $98.1 million (down 23.5% YoY), and the FY2025 annual result was $43.7 million, down 19.66% from the prior year.
- Research & Development came in at $43.7 million for Q4 2025 at Evotec SE, up from -$10186.0 in the prior quarter.
- In the past five years, Research & Development ranged from a high of $82.5 million in Q4 2021 to a low of -$22267.1 in Q1 2021.
- The 5-year median for Research & Development is $18634.9 (2022), against an average of $22.2 million.
- Across the five-year window, Research & Development surged 32.55% in 2023 and slumped 168.44% in 2024, its largest moves.
- Evotec SE's Research & Development stood at $82.5 million in 2021, then fell by 5.33% to $78.1 million in 2022, then slipped by 5.57% to $73.8 million in 2023, then declined by 26.29% to $54.4 million in 2024, then decreased by 19.66% to $43.7 million in 2025.
- The last three Research & Development figures came in at $43.7 million (Q4 2025), -$10186.0 (Q3 2025), and $54.4 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 222.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 180.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 138.20 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 934,363.43 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 296.20 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 97.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 103.35 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 39.38 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 46.94 Mn |
| 10 | Evotec SE | 583.10 Mn | 582.58 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 43.69 Mn |
| Sep 30, 2025 | -10,185.98 |
| Dec 31, 2024 | 54.39 Mn |
| Sep 30, 2024 | -13,040.26 |
| Dec 31, 2023 | 73.79 Mn |
| Sep 30, 2023 | 19,053.60 |
| Jun 30, 2023 | -13,477.62 |
| Dec 31, 2022 | 78.14 Mn |
| Sep 30, 2022 | 18,634.93 |
| Jun 30, 2022 | -19,980.64 |
| Mar 31, 2022 | -20,328.90 |
| Dec 31, 2021 | 82.53 Mn |
| Sep 30, 2021 | 21,271.98 |
| Jun 30, 2021 | -20,441.30 |
| Mar 31, 2021 | -22,267.12 |
| Dec 31, 2020 | 76.19 Mn |
| Sep 30, 2020 | 19,017.47 |